Cargando…

Single-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma

BACKGROUND: Relatlimab plus nivolumab (anti–lymphocyte-activation gene 3 plus anti–programmed death 1 [anti–LAG-3+anti–PD-1]) has been approved by the FDA as a first-line therapy for stage III/IV melanoma, but its detailed effect on the immune system is unknown. METHODS: We evaluated blood samples f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huuhtanen, Jani, Kasanen, Henna, Peltola, Katriina, Lönnberg, Tapio, Glumoff, Virpi, Brück, Oscar, Dufva, Olli, Peltonen, Karita, Vikkula, Johanna, Jokinen, Emmi, Ilander, Mette, Lee, Moon Hee, Mäkelä, Siru, Nyakas, Marta, Li, Bin, Hernberg, Micaela, Bono, Petri, Lähdesmäki, Harri, Kreutzman, Anna, Mustjoki, Satu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Clinical Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014104/ https://www.ncbi.nlm.nih.gov/pubmed/36719749 http://dx.doi.org/10.1172/JCI164809

Ejemplares similares

Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients
por: Kasanen, Henna, et al.
Publicado: (2020)

Evolution and modulation of antigen-specific T cell responses in melanoma patients
por: Huuhtanen, Jani, et al.
Publicado: (2022)

Predicting recognition between T cell receptors and epitopes with TCRGP
por: Jokinen, Emmi, et al.
Publicado: (2021)

Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma
por: Chiaro, Jacopo, et al.
Publicado: (2021)

IFNα induces prolonged remissions modeling curative immunologic responses in chronic myeloid leukemia
por: Ilander, Mette, et al.
Publicado: (2014)

TCRconv: predicting recognition between T cell receptors and epitopes using contextualized motifs
por: Jokinen, Emmi, et al.
Publicado: (2022)

Dasatinib promotes Th1-type responses in granzyme B expressing T-cells
por: Kreutzman, Anna, et al.
Publicado: (2014)

T and NK cell abundance defines two distinct subgroups of renal cell carcinoma
por: Lee, Moon Hee, et al.
Publicado: (2022)

Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-α Monotherapy
por: Ilander, Mette, et al.
Publicado: (2014)

Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma
por: Lee, Moon Hee, et al.
Publicado: (2023)

Immune control in chronic myeloid leukemia
por: Ilander, Mette, et al.
Publicado: (2017)

Immune cell phenotype and functional defects in Netherton syndrome
por: Eränkö, Elina, et al.
Publicado: (2018)

Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8(+) T-cell large granular lymphocytic leukemia
por: Huuhtanen, Jani, et al.
Publicado: (2022)

Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature
por: Kelkka, Tiina, et al.
Publicado: (2020)

Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature
por: Kelkka, Tiina, et al.
Publicado: (2021)

IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
por: Huuhtanen, Jani, et al.
Publicado: (2022)

mGPfusion: predicting protein stability changes with Gaussian process kernel learning and data fusion
por: Jokinen, Emmi, et al.
Publicado: (2018)

S176: FUNCTIONAL AND ANTIGEN-SPECIFIC CHARACTERIZATION OF IMMUNE CELLS AT THE SINGLE-CELL LEVEL REVEALS CONVERGENCE OF ADAPTIVE AND INNATE IMMUNITY IN IMMUNE APLASTIC ANEMIA
por: Huuhtanen, Jani, et al.
Publicado: (2023)

Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia
por: Kelkka, Tiina, et al.
Publicado: (2022)

Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma
por: Karhapää, Hanna, et al.
Publicado: (2022)

Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients
por: Brück, Oscar, et al.
Publicado: (2021)

Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease
por: Kim, Daehong, et al.
Publicado: (2020)

Computational textural mapping harmonises sampling variation and reveals multidimensional histopathological fingerprints
por: Brummer, Otso, et al.
Publicado: (2023)

The tumor and plasma cytokine profiles of renal cell carcinoma patients
por: Lee, Moon Hee, et al.
Publicado: (2022)

Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia
por: Lundgren, Sofie, et al.
Publicado: (2021)

Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
por: Haikala, Heidi M., et al.
Publicado: (2019)

Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia
por: El Missiry, Mohamed, et al.
Publicado: (2017)

TSignal: a transformer model for signal peptide prediction
por: Dumitrescu, Alexandru, et al.
Publicado: (2023)

Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
por: Haikala, Heidi M., et al.
Publicado: (2019)

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
por: Kreutzman, Anna, et al.
Publicado: (2019)

Dominant TOM1 mutation associated with combined immunodeficiency and autoimmune disease
por: Keskitalo, Salla, et al.
Publicado: (2019)

STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation
por: Kim, Daehong, et al.
Publicado: (2021)

High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma
por: Kohtamäki, Laura, et al.
Publicado: (2021)

Somatic mutations and T-cell clonality in patients with immunodeficiency
por: Savola, Paula, et al.
Publicado: (2019)

Phosphodiester models for cleavage of nucleic acids
por: Mikkola, Satu, et al.
Publicado: (2018)

Proteasome Activity Influences UV-Mediated Subnuclear Localization Changes of NPM
por: Moore, Henna M., et al.
Publicado: (2013)

An integrative computational systems biology approach identifies differentially regulated dynamic transcriptome signatures which drive the initiation of human T helper cell differentiation
por: Äijö, Tarmo, et al.
Publicado: (2012)

Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia
por: Kuusanmäki, Heikki, et al.
Publicado: (2020)

Osteoclastogenesis of human peripheral blood, bone marrow, and cord blood monocytes
por: Vuoti, Ella, et al.
Publicado: (2023)

The SCLtTAxBCR-ABL transgenic mouse model closely reflects the differential effects of dasatinib on normal and malignant hematopoiesis in chronic phase-CML patients
por: Schubert, Claudia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lbrpd50t1qfv9qb3epln49ft9s